Ngā hua rapu - Gibson, Michael

Whakamahine hua
  1. 1
    Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma

    Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma mā Das, Satya, Gibson, Michael K

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Acute Urography

    Acute Urography mā Roylance, John, Gibson, Michael J., Davies, Peter

    I whakaputaina 1969
    Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    The Effects of Cooking Process and Meat Inclusion on Pet Food Flavor and Texture Characteristics

    The Effects of Cooking Process and Meat Inclusion on Pet Food Flavor and Texture Characteristics mā Koppel, Kadri, Gibson, Michael, Alavi, Sajid, Aldrich, Greg

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Tracing 25 years of ‘initiativitis’ in central government attempts to join up local public services in England

    Tracing 25 years of ‘initiativitis’ in central government attempts to join up local public services in England mā Gibson, Michael, van Lier, Felix-Anselm, Carter, Eleanor

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Myonecrosis secondary to Clostridium Septicum in a patient with Occult Colon Malignancy: a case report

    Myonecrosis secondary to Clostridium Septicum in a patient with Occult Colon Malignancy: a case report mā Gibson, Michael A, Avgerinos, Dimitrios V, Llaguna, Omar H, Sheth, Nitin D

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    A Rare Case of Malignant Glomus Tumor of the Esophagus

    A Rare Case of Malignant Glomus Tumor of the Esophagus mā Bali, Gurvinder Singh, Hartman, Douglas J., Haight, Joel B., Gibson, Michael K.

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Inherited disorders of GABA metabolism

    Inherited disorders of GABA metabolism mā Pearl, Phillip L, Hartka, Thomas R, Cabalza, Jessica L, Taylor, Jacob, Gibson, Michael K

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    The Effects of Fiber Inclusion on Pet Food Sensory Characteristics and Palatability

    The Effects of Fiber Inclusion on Pet Food Sensory Characteristics and Palatability mā Koppel, Kadri, Monti, Mariana, Gibson, Michael, Alavi, Sajid, Donfrancesco, Brizio Di, Carciofi, Aulus Cavalieri

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Atrial Conduction Slows Immediately Before the Onset of Human Atrial Fibrillation: A Bi-Atrial Contact Mapping Study of Transitions to Atrial Fibrillation

    Atrial Conduction Slows Immediately Before the Onset of Human Atrial Fibrillation: A Bi-Atrial Contact Mapping Study of Transitions to Atrial Fibrillation mā Lalani, Gautam G., Schricker, Amir, Gibson, Michael, Rostamian, Armand, Krummen, David E., Narayan, Sanjiv M.

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes

    Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes mā Gomez-Casal, Roberto, Bhattacharya, Chitralekha, Ganesh, Nandita, Bailey, Lisa, Basse, Per, Gibson, Michael, Epperly, Michael, Levina, Vera

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes

    Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes mā Xu, Xu Steven, Moore, Kenneth, Burton, Paul, Stuyckens, Kim, Mueck, Wolfgang, Rossenu, Stefaan, Plotnikov, Alexei, Gibson, Michael, Vermeulen, An

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma

    A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcino... mā Zahoor, Haris, Luketich, James D., Levy, Ryan M., Awais, Omar, Winger, Daniel G., Gibson, Michael K., Nason, Katie S.

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    MUC2 Expression is an Adverse Prognostic Factor in Superficial Gastroesophageal Adenocarcinomas

    MUC2 Expression is an Adverse Prognostic Factor in Superficial Gastroesophageal Adenocarcinomas mā Davison, Jon M., Ellis, Shane T., Foxwell, Tyler J., Luketich, James D., Gibson, Michael K., Kuan, Shih-Fan, Nason, Katie S.

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    A Novel Pharmacodynamic Approach to Assess and Predict Tumor Response to the Epidermal Growth Factor Receptor Inhibitor Gefitinib in Patients with Esophageal Cancer

    A Novel Pharmacodynamic Approach to Assess and Predict Tumor Response to the Epidermal Growth Factor Receptor Inhibitor Gefitinib in Patients with Esophageal Cancer mā Altiok, Soner, Mezzadra, Heather, Jagannath, Sanjay, Tsottles, Nancy, Rudek, Michelle A, Abdallah, Nadia, Berman, David, Forastiere, Arlene, Gibson, Michael K.

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer

    Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer mā LaPelusa, Michael, Shen, Chan, Gillaspie, Erin A., Cann, Christopher, Lambright, Eric, Chakravarthy, A. Bapsi, Gibson, Michael K., Eng, Cathy

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50‐ to 74‐year‐old adults

    The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50‐ to 74‐year‐old adults mā Kennedy, Richard B., Simon, Whitney L., Gibson, Michael J., Goergen, Krista M., Grill, Diane E., Oberg, Ann L., Poland, Gregory A.

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology

    Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology mā Haralambieva, Iana H., Gibson, Michael J., Kennedy, Richard B., Ovsyannikova, Inna G., Warner, Nathaniel D., Grill, Diane E., Poland, Gregory A.

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

    A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck mā Yao, Min, Galanopoulos, Nicholas, Lavertu, Pierre, Fu, Pingfu, Gibson, Michael, Argiris, Athanassios, Rezaee, Rod, Zender, Chad, Wasman, Jay, Machtay, Mitchell, Savvides, Panos

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Phase II Study of Erlotinib and Docetaxel with Concurrent Intensity Modulated Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

    Phase II Study of Erlotinib and Docetaxel with Concurrent Intensity Modulated Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma mā Yao, Min, Lavertu, Pierre, Savvides, Panayiotis, Woods, Charles, Fu, Pingfu, Gibson, Michael, Rezaee, Rod, Zender, Chad, Wasman, Jay, Sharma, Neelesh, Machtay, Mitchell

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma

    Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma mā Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: